No down-side to starting durvalumab immediately after chemoradiation for unresectable stage III non-small cell lung cancer-some answers but more questions.
Editorial Article
Overview
publication date
- February 27, 2025
published in
- Journal of thoracic disease Journal
Identity
PubMed Central ID
- PMC11898364
Scopus Document Identifier
- 85219521729
Digital Object Identifier (DOI)
- 10.21037/jtd-24-1858
PubMed ID
- 40083527
Additional Document Info
volume
- 17
issue
- 2